Why the study?
Does simvastatin 20 to 40 mg daily reduce mortality and major coronary events in women and elderly patients with established coronary heart disease?
Population
4,444 patients with established coronary heart disease, including 827 women and 1,021 patients >= 65 years…
Comparison
Simvastatin 20 to 40 mg daily vs Placebo
Design
RCT, randomized
Follow-up
median 5.4 years
Authors
Loading...
Supports simvastatin in elderly patients and women with CHD; extends RCT evidence to these subgroups.
Does simvastatin 20 to 40 mg daily reduce mortality and major coronary events in women and elderly patients with established coronary heart disease?
Simvastatin therapy significantly reduces major coronary events in women and elderly patients with established coronary heart disease, with older patients experiencing substantial absolute risk reductions in mortality.
Miettinen et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: